搜索筛选:
搜索耗时4.1337秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[会议论文] 作者：Rajesh Shrotriya,
来源：2014第七届世界癌症大会 年份：2014
In spite of intensive efforts and advances made, cancer remains a challenge and innovative therapies are needed to provide better treatments to cancer patie...
[会议论文] 作者：Rajesh Shrotriya,
来源：2014第七届世界癌症大会 年份：2014
Cytotoxic cancer chemotherapeutic agents continue to play an important role in the treatment of cancer.However, dose-limiting toxicities limit their use and efficacy.Nanomedicne could play an importan...
Pralatrexate, a Next Generation Anti-folate, and its Use in the Treatment of Peripheral T-cell Lymph
[会议论文] 作者：Rajesh Shrotriya,
来源：2013第六届世界癌症大会 年份：2013
Pralatrexate was rationally designed to be a much more potent anti-folate than the widely used methotrexate.Pralatrexate was designed to have higher affinity to reduced folate carrier 1 (RFC1), to enh...
Exciting Recent Developments in Clinical Research and Practice with Ibritumomab Tiuxetan -- The Firs
[会议论文] 作者：Rajesh Shrotriya,
来源：BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会) 年份：2012
Ibritumomab tiuxetan (Zevalin) is currently indicated for the treatment of relapsed or refractory low grade or follicular B-cell Non-Hodgkins lymphoma (NHL), and previously untreated follicular NHL in...
Clinical Studies with Captisol-enabled Melphalan A Novel Cyclodextrin-based, Propylene Glycol-free F
[会议论文] 作者：Rajesh Shrotriya,
来源：2016第九届世界癌症大会 年份：2016
Cytotoxic cancer chemotherapeutic agents continue to play an important role in the treatment of cancer.However,use of many chemotherapeutic agents poses challenges because of their poor aqueous solubi...
相关搜索：
